Intrinsiqs

Is CG Oncology Inc. overvalued?

CG Oncology Inc. (CGON) — key valuation metrics and fundamentals.

No verdict
Price
$67.15
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$5.92B
Dividend yield
0.0%
Return on equity
-25.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CGON's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.